Aglatimagene besadenovec

DB15074Investigational

Aglatimagene besadenovec is under investigation in clinical trial NCT00638612 (AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)).

Mechanism: Pharmacologically active on Thymidine kinase
Curator reviewed
Code names: ADV-TK · CAN-2409

Resolves to

Compound

UNII5Z72SSS34WCAS1621271-62-2

Targets

Q9QNF7TK

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

18Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Aglatimagene besadenovec, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account